{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:37Z","timestamp":1786119217314,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/gme.0b013e31818c91ca","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T15:53:57Z","timestamp":1242921237000},"page":"477-483","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use"],"prefix":"10.1097","volume":"16","author":[{"given":"Aditya","family":"Bardia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Novotny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deb","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-13-20210227","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.fertnstert.2005.10.033","article-title":"Type of menopause, patterns of hormone therapy use, and hot flashes.","volume":"85","author":"Gallicchio","year":"2006","journal-title":"Fertil Steril"},{"key":"R3-13-20210227","first-page":"982","article-title":"Symptom relief and side effects of postmenopausal hormones: results from the postmenopausal estrogen\/progestin interventions trial.","volume":"92","author":"Greendale","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R4-13-20210227","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1634\/theoncologist.11-6-641","article-title":"Symptoms and treatment in cancer therapy-induced early menopause.","volume":"11","author":"Boekhout","year":"2006","journal-title":"Oncologist"},{"key":"R5-13-20210227","first-page":"982","article-title":"Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen\/Progestin Interventions Trial.","volume":"92","author":"Greendale","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R6-13-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0029-7844(97)00264-0","article-title":"Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.","volume":"90","author":"Oddens","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R7-13-20210227","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1471-0528.1997.tb11456.x","article-title":"Prevalence and characteristics associated with use of hormone replacement therapy in Britain.","volume":"104","author":"Moorhead","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"R8-13-20210227","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.1991.03460150089030","article-title":"A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.","volume":"265","author":"Steinberg","year":"1991","journal-title":"JAMA"},{"key":"R9-13-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"suppl 3","key":"R10-13-20210227","first-page":"1S","article-title":"Breast cancer and hormonal contraceptives: further results.","volume":"54","year":"1996","journal-title":"Contraception"},{"key":"R11-13-20210227","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0140-6736(91)91498-J","article-title":"Breast cancer and depot medroxyprogesterone acetate: a national study.","volume":"338","year":"1991","journal-title":"Lancet"},{"key":"R12-13-20210227","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.0.CO;2-0","article-title":"Hot flashes in postmenopausal women treated for breast carcinoma.","volume":"82","author":"Carpenter","year":"1998","journal-title":"Cancer"},{"key":"R13-13-20210227","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1188\/02.ONF.E16-E25","article-title":"Hot flashes and related outcomes in breast cancer survivors and matched comparison women.","volume":"29","author":"Carpenter","year":"2002","journal-title":"Oncol Nurs Forum"},{"key":"R14-13-20210227","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0885-3924(98)00090-6","article-title":"Definitions of hot flashes in breast cancer survivors.","volume":"16","author":"Finck","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"R15-13-20210227","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(00)03394-8","article-title":"Venlafaxine for hot flushes.","volume":"356","author":"Barlow","year":"2000","journal-title":"Lancet"},{"key":"R16-13-20210227","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1001\/jama.295.17.2057","article-title":"Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis review.","volume":"295","author":"Nelson","year":"2006","journal-title":"JAMA"},{"key":"R17-13-20210227","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3816\/SCT.2006.n.022","article-title":"Pilot evaluation of aprepitant for the treatment of hot flashes.","volume":"3","author":"Bardia","year":"2006","journal-title":"Support Cancer Ther"},{"key":"R18-13-20210227","first-page":"47","article-title":"Pilot evaluation of citalopram for the relief of hot.","volume":"1","author":"Barton","year":"2003","journal-title":"Support Oncol"},{"key":"R19-13-20210227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3816\/SCT.2006.n.004","article-title":"Dehydroepiandrosterone for the treatment of hot flashes: a pilot study.","volume":"3","author":"Barton","year":"2006","journal-title":"Support Cancer Ther"},{"key":"R20-13-20210227","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3816\/SCT.2007.n.018","article-title":"Phase II evaluation of desipramine for the treatment of hot flashes.","volume":"4","author":"Barton","year":"2007","journal-title":"Support Cancer Ther"},{"key":"R21-13-20210227","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","article-title":"Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes.","volume":"16","author":"Loprinzi","year":"1998","journal-title":"J Clin Oncol"},{"key":"R22-13-20210227","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/77.11.1159","article-title":"Pilot evaluation of gabapentin for treating hot flashes.","volume":"77","author":"Loprinzi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R23-13-20210227","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1089\/jpm.2005.8.924","article-title":"Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.","volume":"8","author":"Loprinzi","year":"2005","journal-title":"J Palliat Med"},{"key":"R24-13-20210227","first-page":"50","article-title":"Pilot evaluation of mirtazapine for the treatment of hot flashes.","volume":"2","author":"Perez","year":"2004","journal-title":"J Support Oncol"},{"key":"R25-13-20210227","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1089\/jpm.2006.9.631","article-title":"Pilot evaluation of bupropion for the treatment of hot flashes.","volume":"9","author":"Perez","year":"2006","journal-title":"J Palliat Med"},{"key":"R26-13-20210227","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1081\/CNV-200026394","article-title":"Pilot evaluation of black cohosh for the treatment of hot flashes in women.","volume":"22","author":"Pockaj","year":"2004","journal-title":"Cancer Invest"},{"key":"R27-13-20210227","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2310\/7200.2007.007","article-title":"Pilot evaluation of flaxseed for the management of hot flashes.","volume":"5","author":"Pruthi","year":"2007","journal-title":"J Soc Integr Oncol"},{"key":"R28-13-20210227","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00520-007-0276-1","article-title":"Levetiracetam for the treatment of hot flashes: a phase II study.","volume":"16","author":"Thompson","year":"2008","journal-title":"Support Care Cancer"},{"key":"R29-13-20210227","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"key":"R30-13-20210227","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes.","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N Engl J Med"},{"key":"R31-13-20210227","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Randomized phase III controlled trial of venlafaxine in the management of hot flashes.","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"R32-13-20210227","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.2002.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes.","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J Clin Oncol"},{"key":"R33-13-20210227","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J Clin Oncol"},{"key":"R34-13-20210227","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1200\/JCO.2006.07.5390","article-title":"Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5.","volume":"25","author":"Loprinzi","year":"2007","journal-title":"J Clin Oncol"},{"key":"R35-13-20210227","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.2005.05.4296","article-title":"Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1.","volume":"24","author":"Pockaj","year":"2006","journal-title":"J Clin Oncol"},{"key":"R36-13-20210227","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.2000.18.5.1068","article-title":"Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial.","volume":"18","author":"Quella","year":"2000","journal-title":"J Clin Oncol"},{"key":"R37-13-20210227","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","article-title":"Methodologic lessons learned from hot flash studies.","volume":"19","author":"Sloan","year":"2000","journal-title":"J Clin Oncol"},{"key":"R38-13-20210227","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"key":"R39-13-20210227","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flashes with venlafaxine hydrochloride: a randomized, controlled trial.","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R40-13-20210227","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00042192-200512010-00006","article-title":"Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study.","volume":"12","author":"Suvanto-Luukkonen","year":"2005","journal-title":"Menopause"},{"key":"R41-13-20210227","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/gme.0b013e31817dfd2b","article-title":"Newer antidepressants for hot flashes-should their efficacy still be up for debate?","volume":"16","author":"Loprinzi","year":"2009","journal-title":"Menopause"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200916030-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:49:58Z","timestamp":1786038598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200916030-00013"}},"subtitle":["a pooled analysis"],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31818c91ca","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}